NHC (NYSE: NHC) CEO exercises options as 4,492 shares withheld for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
National Healthcare Corp CEO Stephen Fowler Flatt reported routine equity compensation activity. He exercised stock options to acquire a total of 6,000 shares of common stock at exercise prices of $90.62 and $94.10 per share. The company withheld 4,492 shares to pay the option exercise price and related tax obligations, a non‑market transaction. Following these transactions, Flatt beneficially owns 67,013 shares of common stock directly. He also retains unexercised options over 20,000 shares at an exercise price of $157.13 and options over 4,294 shares at $53.94, with expirations extending to 2031.
Positive
- None.
Negative
- None.
Insider Trade Summary
6,000 shares exercised/converted
Mixed
7 txns
Insider
Flatt Stephen Fowler
Role
CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock | 5,000 | $0.00 | -- |
| Exercise | Option to Purchase Common Stock | 1,000 | $0.00 | -- |
| Exercise | Common Stock | 5,000 | $94.10 | $471K |
| Exercise | Common Stock | 1,000 | $90.62 | $91K |
| Tax Withholding | Common Stock | 4,492 | $197.96 | $889K |
| holding | Option to Purchase Common Stock | -- | -- | -- |
| holding | Option to Purchase Common Stock | -- | -- | -- |
Holdings After Transaction:
Option to Purchase Common Stock — 5,000 shares (Direct, null);
Common Stock — 70,505 shares (Direct, null)
Footnotes (1)
- These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Total amount of shares beneficially owned following transactions reported on this form.
Key Figures
Options exercised: 6,000 shares
Shares withheld for exercise and taxes: 4,492 shares
Shares owned after transactions: 67,013 shares
+4 more
7 metrics
Options exercised
6,000 shares
Common stock acquired through option exercises on 2026-05-14
Shares withheld for exercise and taxes
4,492 shares
Common stock withheld by company to cover exercise price and tax obligations
Shares owned after transactions
67,013 shares
Total common shares beneficially owned directly after reported activity
Option exercise price
$90.62/share
Exercise price for 1,000-share option block
Option exercise price
$94.10/share
Exercise price for 5,000-share option block
Unexercised options
20,000 underlying shares
Options at $157.13/share expiring in 2031
Unexercised options
4,294 underlying shares
Options at $53.94/share expiring in 2028
Key Terms
2020 Omnibus Equity Incentive Plan, Rule 16b-3(d), withholding tax obligations, beneficially owned, +1 more
5 terms
2020 Omnibus Equity Incentive Plan financial
"These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024."
Rule 16b-3(d) regulatory
"The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d)."
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
withholding tax obligations financial
"Shares were withheld by the Company to pay the exercise price and withholding tax obligations."
beneficially owned financial
"Total amount of shares beneficially owned following transactions reported on this form."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transactions did NHC CEO Stephen Fowler Flatt report?
Stephen Fowler Flatt exercised stock options for 6,000 NHC shares. These options converted into common stock, and some shares were withheld by the company to cover the option exercise price and tax obligations, reflecting routine equity compensation activity rather than open‑market trading.
How many NHC stock options did the CEO exercise and at what prices?
The CEO exercised options covering 6,000 NHC shares. These consisted of 1,000 shares at an exercise price of $90.62 per share and 5,000 shares at $94.10 per share, converting derivative positions into additional common shares.
What unexercised NHC stock options does the CEO still hold?
The CEO retains significant unexercised NHC stock options. The filing lists options over 20,000 underlying shares at an exercise price of $157.13 and options over 4,294 underlying shares at $53.94, with expiration dates running through 2028 and 2031.
Were the NHC CEO’s option grants tied to an equity incentive plan?
Yes, the options were granted under NHC’s 2020 Omnibus Equity Incentive Plan. Footnotes explain that grants on March 5, 2024 and February 24, 2025 were made pursuant to this plan and are exempt from Section 16(b) under Rule 16b‑3(d).